Ann M. Hanly - Feb 22, 2022 Form 4 Insider Report for Vir Biotechnology, Inc. (VIR)

Role: Chief Technology Officer
Signature: /s/ Howard Horn, Attorney-in-Fact
Stock symbol: VIR
Transactions as of: Feb 22, 2022
Transactions value $: $0
Form type: 4
Date filed: 2/24/2022, 08:33 PM
Previous filing: Dec 1, 2021
Next filing: Mar 31, 2022

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	VIR	Common Stock	Award	$0	+53.5K	+174.84%	$0.00	84.1K	Feb 22, 2022	Direct	F1
holding	VIR	Common Stock						11.5	Feb 22, 2022	See footnote	F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	VIR	Stock Option (Right to Buy)	Award	$0	+47K		$0.00	47K	Feb 22, 2022	Common Stock	47K	$29.48	Direct	F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Acquisition of restricted stock units pursuant to the Issuer's Equity Incentive Plan.
F2	The shares are beneficially owned by the reporting person's spouse, for the benefit of a minor child.
F3	25% of the shares subject to the stock option vest and become exercisable on February 22, 2023, and the remainder vest in 36 equal monthly installments thereafter.